Stains
Cytokeratin 19 (CK19, K19)

Author: Nat Pernick, M.D. (see Authors page)

Revised: 2 December 2016, last major update October 2013

Copyright: (c) 2003-2016, PathologyOutlines.com, Inc.

PubMed Search: CK19[title]
Cite this page: Cytokeratin 19 (CK19, K19). PathologyOutlines.com website. http://www.pathologyoutlines.com/topic/stainsck19.html. Accessed December 7th, 2016.
Definition / General
  • Molecular weight is 40 kDa (smallest cytokeratin)
  • Often coexpressed with CK7
  • Present in both simple and complex epithelium
  • Involved in the organization of myofibers; links contractile apparatus to dystrophin at costameres of striated muscle (also CK8, Mol Biol Cell 2005;16:4280)
  • Polymorphisms of CK19 pseudogene are associated with primary biliary cirrhosis (Hepatol Res 2003;25:281)
Uses by Pathologists
  1. Bladder: possible urine screening test for bladder carcinoma (J Egypt Natl Canc Inst 2006;18:82)
  2. Bone / soft tissue: distinguish chordoma (CK19+) from parachordoma (CK19-, Ann Diagn Pathol 1997;1:3)
  3. Breast: presence of CK19+ peripheral blood tumor cells or CK19+ fragments is a poor prognostic factor for breast cancer (predicts CNS relapse, Breast Cancer Res 2006;8:R36)
  4. Liver: distinguish hepatocellular carcinoma (CK19-) from either hepatoid adenocarcinoma metastatic to liver (CK19+, Am J Surg Pathol 2003;27:1302) or cholangiocarcinoma (CK19+, J Gastrointestin Liver Dis 2006;15:9, Am J Clin Pathol 2006;125:519)
  5. Liver: poor prognostic factor in hepatocellular carcinoma (Histopathology 2006;49:138, Cancer Sci 2003;94:851)
  6. Lung: poor prognostic factor for non small cell lung carcinoma (Ann N Y Acad Sci 2006;1075:244, Cancer 2006;107:2842)
  7. Pancreas: poor prognostic factor in pancreatic endocrine neoplasms (Am J Surg Pathol 2004;28:1145, Am J Surg Pathol 2006;30:1588)
  8. Thyroid: confirm diagnosis of papillary thyroid carcinoma in cytology or equivocal cases (Arch Pathol Lab Med 2003;127:579, Mod Pathol 2006;19:1631); help distinguish follicular variant of papillary thyroid carcinoma (CK19+) from (a) follicular adenoma (CK19-, Endocr Pathol 2006;17:213, Am J Clin Pathol 2006;126:700 but see Am J Clin Pathol 2001;116:696), (b) hyalinizing trabecular adenoma (CK19-, Am J Surg Pathol 2006;30:1269), (c) Grave’s disease (weak / negative CK19, Endocr Pathol 2005;16:63), (d) multinodular goiter with papillary areas (Endocr Pathol 2002;13:207); note that CK19 may stain benign thyroid lesions
  9. Metastases: RT-PCR detects nodal and marrow metastases in various carcinomas - bladder carcinoma (poorer survival, Clin Cancer Res 2005;11:3773), breast (Anticancer Res 2006;26:3855, Jpn J Clin Oncol 2003;33:167), gastric (World J Gastroenterol 2006;12:5219), head and neck squamous cell (Br J Cancer 2006;94:1164), skin (Br J Dermatol 2003;149:998); note that pelvic lymph nodes may have false positives (Int J Cancer 2007;120:1842)
  10. Peripheral blood tumor cells: RT-PCR detects peripheral blood tumor cells in carcinoma of cervix (Gynecol Oncol 2002;85:148), colon (Gut 2002;50:530), gallbladder (Rev Med Chil 2004;132:1489), pancreas (World J Gastroenterol 2007;13:257); the significance of these tumor cells is unclear (Ann Oncol 2005;16:1845)
Positive Staining - Normal
Positive Staining - Not Malignant
Positive Staining - Malignant
Negative Stains
Micro Images
Images hosted on PathOut server:

Courtesy of Andrey Bychkov, M.D., Ph.D.

CK19: clear de-
marcation between
cancer tissue
and thyroid

CK19: prominent membranous and cytoplasmic staining



Images hosted on other servers:

Clear cell odontogenic carcinoma (fig 7B)

Pancreatic ductal carcinoma (fig D)

Squamous cell carcinoma - oral (fig B)

Stomach - complete intestinal metaplasia

Thyroid lesions - various



Images hosted on Nature.com:

Cholangio-
carcinoma
Missing Image

Endolymphatic sac tumor

Missing Image

Renal low grade tubularmucinous neoplasm

Missing Image

Thyroid papillary carcinoma

Missing Image

Follicular variant (fig D)

Missing Image

Thyroid nodular goiter has focal CK19+ (fig I)

Additional References